- Global Pharma News & Resources

MEDICLIN will continue to grow - about 50 Millionen Euros will be invested

DGAP-News: MediClin AG / Key word(s): Annual Results

29.03.2019 / 13:30
The issuer is solely responsible for the content of this announcement.

Offenburg, 29 March 2019

MEDICLIN will continue to grow - about 50 Millionen Euros will be invested

The Management Board of MEDICLIN Aktiengesellschaft (MEDICLILN) was satisfied with the business development of the 2018 financial year at this year's press conference. "Group sales and Group EBIT improved year-on-year despite higher personnel expenses ", said Tino Fritz, CFO of MEDICLIN.

Dividend for the 2018 financial year

The members of the Management Board informed about the agreement with the Supervisory Board to propose to the Annual General Meeting on May 29, 2019, the payment of a dividend of 5 euro cents per share.

MEDICLIN will continue to grow

"In the previous year we invested close to 50 million - more than in the years before and we will do so in 2019", said Volker Hippler, CEO of MEDICLIN and added: "We aim to invest where the demand is increasing and we enlarge our capacities if we can connect acute and post-acute services".

Two new hospital buildings are to be completed in 2021 and 2022, respectively: At the location Lingen a new hospital building for Neurology, Neurological intensive care and Neurophysiology with about 70 beds for 30 million Euros and at the location Röbel a clinic for child and adolescent psychiatry with in total 56 beds for 20 million Euros. "Both projects are funded by the states, one with 20 million Euros and the other one with 15 million Euros. The common target is to secure the specific medical care in these regions, explained Ulf Ludwig, Member of the Management Board of MEDICLIN.

The capacity expansions and our future growth we will finance partially through cash flow but also using our credit lines", added the CFO Tino Fritz.


For FY 2019 the Management Board forecasts sales growth of 5.0 % to 6.0 % and a Group EBIT above previous year's level in the range of EUR 22 mill. to EUR 28 mill.

The annual report 2018 is available under in German and English from today.


About MEDICLIN AG (Ticker: MED; WKN: 659 510)

MEDICLIN owns 36 clinics, seven nursing care facilities, three home nursing care services and nine medical care centres. The Group has about 8,300 beds and a headcount of about 10,000. With its strong network, MEDICLIN can offer its patients integrated care from the first visit to the doctor to surgery, post-operative rehabilitation and follow-up care at home. Doctors, therapists and nurses work together closely to achieve the best results. MEDICLIN plans the care of persons in need in accordance with their individual requirements and personal needs, either at home or in a nursing care facility.

MEDICLIN - A company of the Asklepios Group.

29.03.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 793411

End of News DGAP News Service

Editor Details

Last Updated: 29-Mar-2019